Farther Finance Advisors, LLC Neogenomics Inc Transaction History
Farther Finance Advisors, LLC
- $2.77 Trillion
- Q4 2024
A detailed history of Farther Finance Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 59 shares of NEO stock, worth $820. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 70
15.71%
Holding current value
$820
Previous $1.03 Million
5.81%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NEO
# of Institutions
290Shares Held
124MCall Options Held
712KPut Options Held
110K-
Black Rock Inc. New York, NY19.7MShares$274 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$198 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$95.8 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$91.9 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$91 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.75B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...